TPMT and DPD polymorphisms: Efficient screening method for Indian patients considering taking Thiopurine and 5-FU drugs

Disease Markers

Volumn 27, Issue 5, 2009, Pages 231-238

  Ashavaid, T F ^a   Raghavan, Rani ^a   Shah, Swarup ^a   Kapadia, Asha ^a   Almel, Sachin ^a   Desai, Devendra ^a  

^a P D HINDUJA NATIONAL HOSPITAL   (India)

Author keywords

A719G; Acute lymphoblastic leukemia (ALL); Azathioprine; Cancer; Chemotherapy; Diagnosis; G238C; G460A; Genetic tests; PCR; Pharmacogenomics; SNP's; Toxicity

Indexed keywords

ALANINE; DIHYDROPYRIMIDINE DEHYDROGENASE; DNA; FLUOROURACIL; GLYCINE; MERCAPTOPURINE; THIOPURINE METHYLTRANSFERASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADENOID CYSTIC CARCINOMA; ALLELE; ARTICLE; BREAST CANCER; COLON CANCER; DNA SEQUENCE; DRUG WITHDRAWAL; ENTERITIS; ESOPHAGUS CANCER; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HEALTH STATUS; HISTIOCYTOSIS X; HOMOZYGOTE; HUMAN; INDIA; NEUTROPENIA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RECTUM CANCER; SCREENING TEST; SIGMOID CARCINOMA; SQUAMOUS CELL CARCINOMA; STOMACH CANCER; TREATMENT RESPONSE; VALIDATION PROCESS; WILD TYPE;

EID: 77249139170     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2009/618407     Document Type: Article

References (16)

1. A.B.P. van Kuilenburg, J. Sajes, D.J. Richel, L. Zoetekouw, H.V. Lenthe, R.A. De Abreu, J.G. Maring, P. Vreken and A.H. van Gennip, Clinical implications of Dihydropyrimidine Dehydrogenase (DPD) deficiency in patients with severe 5- Fluorouracil-associated toxicity: Identification of new mutations in the DPD gene, Clinical Cancer Research 6 (2000), 4705-4712.
2. A.B.P. van Kuilenburg, E.W. Muller, J. Sajes, R. Meinsma, L. Zoetekouw, H.R. Waterham, F. Baas, D.J. Richel and A.H. van Gennip, Lethal outcome of a patient with a complete Dihydropyrimidine Dehydrogenase (DPD) deficiency after administration of 5-Fluorouracil: Frequency of the common IVS14+1G>A mutation causing DPD deficiency, Clinical Cancer Research 7 (2001), 1149-1153.
3. C.R. Yates, E.Y. Krynetski, T. Loennechen, M.Y. Fessing, H. Tai, C. Pui, M.V. Relling andW.E. Evans, Molecular diagnosis of thiopurine S-methyltransferase deficiency: Genetic basis for Azathioprine and Mercaptopurine intolerance, Annals of Internal Medicine 126 (1997), 608-614.
4. D. Otterness, B.S.C. Szumlanski, B.S.L. Lennard, B. Klemetsdal, J. Aarbakke, J. Ok Park-Hah, H. Iven, K Schmiegelow, E. Branum, J. O'Brien, R. Weinshilboum, Human thiopurine methyltransferase pharmacogenetics: Gene sequence polymorphisms, Clin Pharmacol Ther 62 (1997), 60-73.
5. E. Topic, Pharmacogenetic and tumor drugs - 2005 http:// www.ifcc.org/ejifcc/vol16no2/160206200512.htm
6. E. Gross, K. Seck, S. Neubauer, J. Mayr, H. Hellebrand, A. Ratanaphan, V. Lutz, H. Stokinger and M. Kiechle, High throughput genotyping by DHPLC of the Dihydropyrimidine Dehydrogenase gene implicated in (fluoro)pyrimidine catabolism, International Journal of Oncology 22 (2003), 325-332.
7. E.Y. Krynetski, J.D. Schuetz, A.J. Galpin, C. Pui, M.V. Relling and W.E. Evans, A single point mutsion leading to loss of catalytic activity in human thiopurine S-Methyltransferase, Proceedings of National Academy of Sciences USA 92 (1995) 949-953.
8. G. Stocco, S. Martelossi, G. Decorti, A. Ventura, N. Malusaq, F. Biartoli and T. Giraldi, Pharmacogenetics of thiopurines: can posology be guided by laboratory data, Radiol Oncol 38 (2004), 101-109.
9. H. Tai, E.Y. Krynetski, E.G. Schetz, Y. Yanishevski and W.E. Evans, Enhanced proteolysis of thiopurine Smethyltransferase (TPMT) encoded by mutant allele in humans (TPMT *3A, TPMT*2): Mechanisms for the genetic polymorphism of TPMT activity, Proceedings of National Academy of Sciences USA 94 (1997), 6444-6449.
10. J.T. Chowning, Pharmacogenetics. Treating disease using an understanding of genetics, from http://www.nwabr.org/ education/pdfs/Pharmacogenetics/TPMT LESSON.pdf
11. M.R. Johnson, K. Wang and R.B. Diasio, Profound Dihydropyrimidine Dehydrogenase Deficiency resulting from a novel compound heterozygote genotype, Clincal Cancer Research 8 (2002), 768-774.
12. M. Raida, W. Schwabe, P. Hausler, A.B.P. Van Kuilenburg, A.H. Van Gennip, D. Behnke and K. Hoffken, Prevalence of a common point mutation in the Dihydropyrimidine Dehydrogenase (DPD) gene within the 5'-splice donor site of intron 14 in patients with severe 5-Fluorouracil (5-FU)-related toxicity compared with controls, Clinical Cancer Research 7 (2001), 2832-2839.
13. N. von Ahsen, V.W. Armstrong and M. Oellerich, Rapid, long-range molecular haplotyping of Thiopurine Smethyltransferase (TPMT) *3A, *3B and *3C, Molecular Diagnostics and Genetics 50 (2004), 1528-1534.
14. R.B. Diasio and M.R. Johnson, Dihydropyrimidine Dehydrogenase : Its role in 5-Fluorouracil Clinical Toxicity and Tumor Resistance, Clinical Cancer Research 5 (1999), 2672-2673.
15. S.A. Ridge, J. Sludden, O. Brown, L. Robertson, X. Wei, A. Sapone, P.M. Fernandez-Salguero, F.J. Gonzalez, P. Vreken, A.B.P. van Kuilenburg, A.H. van Gennip and H.L. McLeod, Dihydropyrimidine Dehydrogenase pharmacogenetics in Caucasian subjects, British Journal of Clinical Pharmacology 46 (1998), 151-156. (Pubitemid 28342786)
16. S.K. Miller, D.D. Dykes and H.F. Polesky, A simple salting out procedure for extracting DNAfrom human nucleated cells, Nucleic Acids Res 19 (1998), 1215.